Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock Has Average Target Price of $30.69

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received an average rating of “Hold” from the fifteen research firms that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $30.69.

A number of equities research analysts recently issued reports on the company. KeyCorp boosted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. UBS Group boosted their target price on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 9th. Raymond James Financial cut Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price target on the stock. in a report on Monday, September 28th. TD Cowen lifted their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Guggenheim increased their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th.

Acadia Healthcare Trading Up 4.8%

NASDAQ:ACHC opened at $31.67 on Thursday. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $35.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm’s 50 day moving average is $28.89 and its 200 day moving average is $27.84. The stock has a market capitalization of $2.95 billion, a PE ratio of -2.54, a price-to-earnings-growth ratio of 9.74 and a beta of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The business had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same period in the prior year, the company earned $0.83 earnings per share. Acadia Healthcare’s revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts expect that Acadia Healthcare will post 1.55 earnings per share for the current year.

Hedge Funds Weigh In On Acadia Healthcare

A number of large investors have recently modified their holdings of the company. Allworth Financial LP purchased a new stake in Acadia Healthcare during the 2nd quarter valued at about $45,000. Global Retirement Partners LLC purchased a new position in Acadia Healthcare in the 2nd quarter worth approximately $68,000. Caitong International Asset Management Co. Ltd increased its stake in Acadia Healthcare by 4,264.8% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares during the period. Integrated Wealth Concepts LLC bought a new stake in Acadia Healthcare in the second quarter valued at approximately $79,000. Finally, Quantbot Technologies LP bought a new stake in Acadia Healthcare in the second quarter valued at approximately $88,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a provider of behavioral healthcare services. The company operates a network of psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics that provide care for individuals with mental health conditions, substance use disorders and other behavioral health needs.

Acadia’s services are designed for children, adolescents and adults and may include inpatient psychiatric treatment, addiction treatment, residential care, partial hospitalization and intensive outpatient programs.